$Tenax Therapeutics(TENX.US)$ NEWS Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
$Tenax Therapeutics(TENX.US)$Benzinga· 1 min ago Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
Tenax Therapeutics股票討論區
NEWS
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
📊⚡️📊
Hearing Tenax Therapeutics To Be Issued U.S. Patent Titled 'LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION'
暫無評論